Scientific harassment by pharmaceutical companies:...[CMAJ. 2000]

SearchDatabase nameforSearch term

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

1: CMAJ. 2000 Jan 25;162(2):212-3. Links

Scientific harassment by pharmaceutical companies: time to stop.

Alberta Heritage Foundation for Medical Research, Edmonton. dhailey@ahfmr.ab.ca

PMID: 10674057 [PubMed - indexed for MEDLINE]

PMCID: PMC1232274

The changing environment for technological innovation in health care.
Baxter Health Policy Rev. 1996; 2:267-315.

[Baxter Health Policy Rev. 1996]
Evidence-based promotion.
Am J Psychiatry. 2004 Oct; 161(10):1928; author reply 1929.

[Am J Psychiatry. 2004]
[Clinical research and pharmaceutical industry. A relationship with advantages and disadvantages]
Ned Tijdschr Geneeskd. 1999 Jul 24; 143(30):1572-6.

[Ned Tijdschr Geneeskd. 1999]
ReviewEvidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications.
BMJ. 2003 May 31; 326(7400):1171-3.

[BMJ. 2003]
ReviewCommercialism and medicine: an overview.
Camb Q Healthc Ethics. 2007 Fall; 16(4):377-86; discussion 439-42.

[Camb Q Healthc Ethics. 2007]
» See reviews... | » See all...

Finer nuances of clinical study agreements for research trials.
Nayak BK. Indian J Ophthalmol. 2008 Jul-Aug; 56(4):267-8.

[Indian J Ophthalmol. 2008]
Dancing with the porcupine: rules for governing the university-industry relationship.
Lewis S, Baird P, Evans RG, Ghali WA, Wright CJ, Gibson E, Baylis F. CMAJ. 2001 Sep 18; 165(6):783-5.

[CMAJ. 2001]
Why randomized controlled trials fail but needn't: a new series is launched.
Sackett DL, Hoey J. CMAJ. 2000 May 2; 162(9):1301-2.

[CMAJ. 2000]

Your browsing activity is empty.

Activity recording is turned off.

Display Show